- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Randomized Double-blind Controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of ExPEC9V and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older
This study looks at a new vaccine to prevent serious E. coli infections and a strong flu vaccine in people aged 65 and over. Researchers want to see how well they work, how safe they are, and if they can be given together.
For: Prevention of invasive extraintestinal pathogenic Escherichia coli (ExPEC) diseaseBelgium · Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years
This study is testing a new vaccine to prevent serious infections caused by certain types of E. coli bacteria in adults aged 60 and over who have had urinary tract infections. It compares the vaccine to a dummy treatment.
For: Invasive Extraintestinal Pathogenic Escherichia coli DiseaseNetherlands · Czechia · Germany